AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
EPS Over TimeExpanding
Percentile Rank67
Studio
Year-over-Year Change

Earnings per share

Latest
-1.16
↑ 26% vs avg
Percentile
P67
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-1.57
Historical baseline
PeriodValueYoY Change
TTM-1.16+32.6%
2024-1.72+37.2%
2023-2.74+1.8%
2022-2.79-86.0%
2021-1.50-92.3%
2020-0.78-160.0%
2019-0.30-